Related Experiment Video
Updated: Jun 27, 2026

In Situ Detection of Ribonucleoprotein Complex Assembly in the C. elegans Germline using Proximity Ligation Assay
Published on: May 5, 2020
DLC1 interacts with 14-3-3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttling
Rolf-Peter Scholz1, Jennifer Regner, Anke Theil
1University of Stuttgart, Institute of Cell Biology and Immunology, Allmandring 31, 70569 Stuttgart, Germany.
Abstract:
Deleted in liver cancer 1 (DLC1) is a Rho-GTPase-activating protein (GAP) that is downregulated in various tumor types. In vitro, DLC1 specifically inactivates the small GTPases RhoA, RhoB and RhoC through its GAP domain and this appears to contribute to its tumor suppressor function in vivo. Molecular mechanisms that control DLC1 activity have not so far been investigated. Here, we show that phorbol-ester-induced activation of protein kinase C and protein kinase D stimulates association of DLC1 with the phosphoserine/phosphothreonine-binding 14-3-3 adaptor proteins via recognition motifs that involve Ser327 and Ser431. Association with 14-3-3 proteins inhibits DLC1 GAP activity and facilitates signaling by active Rho. We further show that treatment of cells with phorbol ester or coexpression of 14-3-3 proteins, blocks DLC1 nucleocytoplasmic shuttling, probably by masking a previously unrecognized nuclear localization sequence. The binding to 14-3-3 proteins is thus a newly discovered mechanism by which DLC1 activity is regulated and compartmentalized.
Insights
Protein kinase activation stimulates 14-3-3 protein binding, inhibiting DLC1 tumor suppressor activity. This binding also blocks DLC1’s movement between the nucleus and cytoplasm, revealing a new regulatory mechanism.
Area of Science:
- Molecular biology
- Cell signaling
- Cancer research
Background:
- Deleted in liver cancer 1 (DLC1) is a Rho-GTPase-activating protein (GAP) with tumor suppressor functions.
- DLC1 is downregulated in various cancer types.
- Mechanisms regulating DLC1 activity remain largely uninvestigated.
Purpose of the Study:
- To investigate the molecular mechanisms controlling DLC1 activity and localization.
- To identify how DLC1’s tumor suppressor function is regulated.
Main Methods:
- Investigated DLC1 association with 14-3-3 proteins upon phorbol ester treatment.
- Utilized in vitro assays to assess DLC1 GAP activity.
- Examined DLC1 nucleocytoplasmic shuttling in response to protein kinase activation and 14-3-3 protein coexpression.
Main Results:
- Phorbol ester-induced activation of protein kinase C and D stimulates DLC1 binding to 14-3-3 proteins via Ser327 and Ser431.
- 14-3-3 binding inhibits DLC1’s Rho-GAP activity, promoting Rho signaling.
- 14-3-3 binding blocks DLC1 nucleocytoplasmic shuttling, potentially by masking a nuclear localization sequence.
Conclusions:
- 14-3-3 protein binding represents a novel mechanism for regulating DLC1 activity and subcellular localization.
- This regulation impacts DLC1’s tumor suppressor function by modulating Rho signaling.
- Understanding DLC1 regulation by 14-3-3 proteins offers potential therapeutic targets in cancer.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Regulation of Nuclear Protein Sorting
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Directing Proteins to the Rough Endoplasmic Reticulum
Rab Cascades
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

